Eden Research
Market Cap
UK£34.9m
Last Updated
2021/04/16 18:49 UTC
Data Sources
Company Financials
Executive Summary
Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. More Details
Risk Analysis
Snowflake Analysis
Adequate balance sheet and overvalued.
Share Price & News
How has Eden Research's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EDEN is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: EDEN's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
Market Performance
7 Day Return
0%
EDEN
2.6%
GB Chemicals
1.6%
GB Market
1 Year Return
100.0%
EDEN
51.1%
GB Chemicals
23.3%
GB Market
Return vs Industry: EDEN exceeded the UK Chemicals industry which returned 51.1% over the past year.
Return vs Market: EDEN exceeded the UK Market which returned 23.3% over the past year.
Shareholder returns
| EDEN | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | 2.6% | 1.6% |
| 30 Day | -7.7% | 7.6% | 4.9% |
| 90 Day | 12.4% | 9.6% | 4.0% |
| 1 Year | 100.0%100.0% | 52.9%51.1% | 30.4%23.3% |
| 3 Year | 33.3%33.3% | 12.2%1.9% | 17.3%2.6% |
| 5 Year | 33.3%33.3% | 47.5%24.0% | 48.5%19.8% |
Long-Term Price Volatility Vs. Market
How volatile is Eden Research's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash Wisely3 months ago | Simply Wall St
A Look At Eden Research's (LON:EDEN) Share Price Returns4 months ago | Simply Wall St
We're Hopeful That Eden Research (LON:EDEN) Will Use Its Cash WiselyValuation
Is Eden Research undervalued compared to its fair value and its price relative to the market?
2.38x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate EDEN's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate EDEN's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: EDEN is unprofitable, so we can't compare its PE Ratio to the GB Chemicals industry average.
PE vs Market: EDEN is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EDEN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EDEN is good value based on its PB Ratio (2.4x) compared to the GB Chemicals industry average (3.4x).
Future Growth
How is Eden Research forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
22.0%
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eden Research has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Eden Research performed over the past 5 years?
15.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EDEN is currently unprofitable.
Growing Profit Margin: EDEN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EDEN is unprofitable, but has reduced losses over the past 5 years at a rate of 15.9% per year.
Accelerating Growth: Unable to compare EDEN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EDEN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-27%).
Return on Equity
High ROE: EDEN has a negative Return on Equity (-9.36%), as it is currently unprofitable.
Financial Health
How is Eden Research's financial position?
Financial Position Analysis
Short Term Liabilities: EDEN's short term assets (£11.0M) exceed its short term liabilities (£1.2M).
Long Term Liabilities: EDEN's short term assets (£11.0M) exceed its long term liabilities (£409.0K).
Debt to Equity History and Analysis
Debt Level: EDEN is debt free.
Reducing Debt: EDEN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if EDEN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if EDEN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Dividend
What is Eden Research current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EDEN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EDEN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EDEN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EDEN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EDEN's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
6.6yrs
Average management tenure
CEO
Sean Smith
6.58yrs
Tenure
UK£349,368
Compensation
Mr. Sean M. Smith has been the Chief Executive Officer of Eden Research PLC since September 1, 2014. Mr. Smith served as the Head of Europe and Innovation Advisor at Intellectual Ventures - Invention Devel...
CEO Compensation Analysis
Compensation vs Market: Sean's total compensation ($USD482.86K) is above average for companies of similar size in the UK market ($USD339.43K).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: EDEN's management team is seasoned and experienced (6.6 years average tenure).
Board Members
Experienced Board: EDEN's board of directors are considered experienced (6.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Eden Research plc's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Eden Research plc
- Ticker: EDEN
- Exchange: AIM
- Founded: 1995
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: UK£34.888m
- Shares outstanding: 380.34m
- Website: https://www.edenresearch.com
Number of Employees
Location
- Eden Research plc
- 67C Innovation Drive
- Milton Park
- Oxfordshire
- Oxfordshire
- OX14 4RQ
- United Kingdom
Listings
Biography
Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides various plant protection products, su...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/16 18:49 |
| End of Day Share Price | 2021/04/16 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.